Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Antony C P, Riddick"'
Autor:
Ines Horvat-Menih, Hao Li, Andrew N. Priest, Shaohang Li, Andrew B. Gill, Iosif A. Mendichovszky, Susan T. Francis, Anne Y. Warren, Brent O’Carrigan, Sarah J. Welsh, James O. Jones, Antony C. P. Riddick, James N. Armitage, Thomas J. Mitchell, Grant D. Stewart, Ferdia A. Gallagher
Publikováno v:
European Radiology Experimental, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background Clinical imaging tools to probe aggressiveness of renal masses are lacking, and T2-weighted imaging as an integral part of magnetic resonance imaging protocol only provides qualitative information. We developed high-resolution and
Externí odkaz:
https://doaj.org/article/b6c4ff0758a645e8b1e1748405028287
Autor:
Christopher G. Smith, Tina Moser, Florent Mouliere, Johanna Field-Rayner, Matthew Eldridge, Anja L. Riediger, Dineika Chandrananda, Katrin Heider, Jonathan C. M. Wan, Anne Y. Warren, James Morris, Irena Hudecova, Wendy N. Cooper, Thomas J. Mitchell, Davina Gale, Andrea Ruiz-Valdepenas, Tobias Klatte, Stephan Ursprung, Evis Sala, Antony C. P. Riddick, Tevita F. Aho, James N. Armitage, Samantha Perakis, Martin Pichler, Maximilian Seles, Gabriel Wcislo, Sarah J. Welsh, Athena Matakidou, Tim Eisen, Charles E. Massie, Nitzan Rosenfeld, Ellen Heitzer, Grant D. Stewart
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-17 (2020)
Abstract Background Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of cancers, but its utility in renal cell cancer (RCC) has not been established. Methods Here, a combination of untargeted and targeted sequencing methods, applied
Externí odkaz:
https://doaj.org/article/2a2d59f651d64baaa2bf45b983922529
Autor:
Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. ‘Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart
Publikováno v:
BMC Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background The current World Health Organization classification recognises 12 major subtypes of renal cell carcinoma (RCC). Although these subtypes differ on molecular and clinical levels, they are generally managed as the same disease, simp
Externí odkaz:
https://doaj.org/article/881cc95bca894f10a09de5f52493ef70
Publikováno v:
BJU International. 131:566-568
Autor:
Rafia S. Al-Lamki, Nicholas J. Hudson, John R. Bradley, Anne Y. Warren, Tim Eisen, Sarah J. Welsh, Antony C. P. Riddick, Fiach C. O’Mahony, Arran Turnbull, Thomas Powles, SCOTRRCC Collaborative, Antonio Reverter, David J. Harrison, Grant D. Stewart
Publikováno v:
Biology, Vol 9, Iss 4, p 74 (2020)
Anti-angiogenic agents, such as the multi-tyrosine kinase inhibitor sunitinib, are key first line therapies for metastatic clear cell renal cell carcinoma (ccRCC), but their mechanism of action is not fully understood. Here, we take steps towards val
Externí odkaz:
https://doaj.org/article/bdec240a0b9e42e0af0a9f88f0e82598
Autor:
Grant D, Stewart, Sarah J, Welsh, Stephan, Ursprung, Ferdia A, Gallagher, James O, Jones, Jacqui, Shields, Christopher G, Smith, Thomas J, Mitchell, Anne Y, Warren, Axel, Bex, Ekaterini, Boleti, Jade, Carruthers, Tim, Eisen, Kate, Fife, Abdel, Hamid, Alexander, Laird, Steve, Leung, Jahangeer, Malik, Iosif A, Mendichovszky, Faiz, Mumtaz, Grenville, Oades, Andrew N, Priest, Antony C P, Riddick, Balaji, Venugopal, Michelle, Welsh, Kathleen, Riddle, Lisa E M, Hopcroft, Alison, Fielding
Publikováno v:
British journal of cancer. 127(6)
Surgery for renal cell carcinoma (RCC) with venous tumour thrombus (VTT) extension into the renal vein (RV) and/or inferior vena cava (IVC) has high peri-surgical morbidity/mortality. NAXIVA assessed the response of VTT to axitinib, a potent tyrosine
Autor:
Brigid Orr, O. Cathal Grace, Pam Brown, Antony C. P. Riddick, Grant D. Stewart, Omar E. Franco, Simon W. Hayward, Axel A. Thomson
Publikováno v:
Disease Models & Mechanisms, Vol 6, Iss 2, Pp 530-536 (2013)
SUMMARY Human prostatic cancer-associated fibroblasts (CAFs) can elicit malignant changes in initiated but non-tumorigenic human prostate epithelium, demonstrating that they possess pro-tumorigenic properties. We set out to reduce the pro-tumorigenic
Externí odkaz:
https://doaj.org/article/dbdb5fb3732b445f97114d602a98b0c6
Autor:
Joana B. Neves, Anne Y. Warren, Tim Butler, Georgina Bowyer, Grant D. Stewart, Andrew R. J. Lawson, Yvette Hooks, Kevin W. Loudon, Matthew D. Young, Liam Bolt, Thomas J. Mitchell, Tev Aho, Lira Mamanova, Antony C. P. Riddick, Eirini S. Fasouli, Sarah J. Welsh, Sarah A. Teichmann, Vincent Gnanapragasam, Maxine G. B. Tran, Ruoyan Li, Sam Behjati, Menna R. Clatworthy, John R. Ferdinand, James N. Armitage, Peter J. Campbell, Thomas R. W. Oliver, Kerstin B. Meyer
Tumour behaviour is dependent on the oncogenic properties of cancer cells and their multi-cellular interactions. These dependencies were examined through 270,000 single cell transcriptomes and 100 micro-dissected whole exomes obtained from 12 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75eabc6ada904e3150ce9f229399b438
https://doi.org/10.1101/2021.11.12.468373
https://doi.org/10.1101/2021.11.12.468373
Autor:
Ferdia A. Gallagher, Andrew N. Priest, Sarah J. Welsh, Athena Matakidou, Fulvio Zaccagna, Anne Y. Warren, Nicola Thompson, Victoria Ingleson, James N. Armitage, Timothy Eisen, Wendi Qian, Stephen Connolly, Kate Fife, Stephan Ursprung, Tristan Barrett, Jean Mullin, Antony C. P. Riddick, Grant D. Stewart, Andrea Machin
Publikováno v:
BJU internationalReferences. 130(2)
Objective: To explore translational biological and imaging biomarkers for sunitinib treatment before and after debulking nephrectomy in the NeoSun (European Union Drug Regulating Authorities Clinical Trials Database [EudraCT] number: 2005-004502-82)
Autor:
Alexander Laird, Fiach C O'Mahony, Jyoti Nanda, Antony C P Riddick, Marie O'Donnell, David J Harrison, Grant D Stewart
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60483 (2013)
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects one third of patients at diagnosis with a further third developing metastatic disease after extirpative surgery. Heterogeneity in the clinical course
Externí odkaz:
https://doaj.org/article/a7361a2fec1345fa971f95bf8789058f